Akarkara for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

Akarkara for Health & Longevity

Created on 08/25/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

A root with a long trading history and an immediate tingling effect on the mouth. Animal and laboratory work shows nerve-signalling and hormone effects in male rodents; almost no human evidence exists. Documented harms are mouth tingling, heavy salivation, and liver and kidney changes in animals near commonly sold amounts. Material identity is frequently uncertain. (Full Review)

Protocol

Traditional whole-root approach
Root powder 250 mg to 1 g daily
With warm milk or honey, as codified in Ayurvedic Vajikarana practice; the longest use record.
Timing within the day
With a fat-containing meal
The alkylamides are fat-soluble; morning dosing while sedation sensitivity is unknown.
Half-life and dose splitting
Two daily doses
A rodent-implied half-life near two hours argues against a single high peak.
Time to effect
Systemic effects
25 to 56 days
Every systemic effect in animals needed daily dosing over this span; less than a month cannot be judged.
Oral tingling and salivation
Immediate
Onset within seconds to minutes of oral contact; subsides over roughly fifteen to thirty minutes.

Benefits

Contraindications
  • Pregnant or breastfeeding women
  • Known daisy-family (Asteraceae) contact allergy
  • Active liver disease or transaminases above twice the upper limit of normal
  • Autoimmune disease or immunosuppressive therapy
  • Hormone-sensitive prostate disease (active prostate cancer, untreated benign prostatic hyperplasia above moderate symptom score)
  • Children and adolescents under 18
  • Epilepsy, where it would replace prescribed antiepileptic therapy
    •
Key Interactions
  • Sedatives and central depressants (diazepam, zolpidem, alcohol)
  • Opioid analgesics (morphine, tramadol, codeine)
  • Antiepileptic drugs (valproate, carbamazepine)
  • Drugs metabolized by CYP3A4 (simvastatin, tacrolimus)
  • Over-the-counter analgesics and anti-inflammatories (ibuprofen, aspirin)
  • Over-the-counter antihistamines and sleep aids (diphenhydramine, doxylamine)
  • Androgenic and pro-fertility supplements (Tribulus terrestris, ashwagandha)
  • Immunostimulant supplements (echinacea, astragalus)
  • Topical or dental anaesthetics (benzocaine, lidocaine)
  • Dental and oral procedures
    •

Risk & Side Effects

  • Medium: Oral Tingling, Numbness, and Hypersalivation
    •
  • Low: Dose-Dependent Liver and Kidney Injury; Sedation and Central Nervous System Depression; Allergic Reactions in Daisy-Family–Sensitive People; Cytotoxicity of Concentrated Extract to Cultured Cells
  • Speculative: Stimulation of Androgen-Sensitive Tissue; Immune Activation in Autoimmune Disease; Adverse Effects in Pregnancy

Monitoring

Marker Target Why
Total testosterone (men) 600–900 ng/dL Headroom for the main claimed effect
Luteinizing hormone 2–6 IU/L Distinguishes a pituitary from a testicular rise
Alanine aminotransferase (ALT) Under 25 U/L in men, under 20 U/L in women Clearest safety signal in the animal data
Aspartate aminotransferase (AST) Under 25 U/L Rose earliest at the lowest animal dose
Estimated glomerular filtration rate (eGFR) Above 90 mL/min/1.73 m² Kidney changes accompanied liver findings at high animal doses
Prostate-specific antigen (PSA) Under 1.0 ng/mL under age 50, under 2.5 ng/mL thereafter Covers the speculative androgen-sensitive-tissue concern
High-sensitivity C-reactive protein (hs-CRP) Under 0.5 mg/L Tracks the anti-inflammatory direction the animal data suggest
Semen analysis (concentration and total motility) No established target — track change from baseline Endpoint with the most animal support

Cadence: Full panel at baseline; liver panel at eight weeks; hormones and semen analysis at twelve weeks; then every six to twelve months.

Qualitative Assessment

  • Libido and spontaneous sexual interest, rated weekly
  • Oral tingling intensity and duration, indicating whether the material is active
  • Daytime drowsiness or mental dulling, the earliest sign of sedation
  • Joint or muscle pain levels, where the anti-inflammatory signal would show
  • Digestive comfort, since the root's fermentable fibre can mimic a drug effect
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.